Skip to main content

Day: December 13, 2021

EuroDry Ltd. Announces the Redemption of its Outstanding Series B Preferred Shares

ATHENS, Greece, Dec. 13, 2021 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today that it provided a notice of redemption to its Series B Preferred Shares (“Preferred Shares”) holders for entire of the outstanding amount at par as per the provisions of the Statement of Designation of the Preferred Shares. The Preferred Shares carried a dividend of 8% per annum until January 2023 increasing to 14% per annum thereafter. The Company will use own funds for the redemption which will take place on or about December 20, 2021. Aristides Pittas, Chairman and CEO of EuroDry commented: “We are very pleased to announce the redemption of the outstanding Series B Preferred Shares at par. This redemption...

Continue reading

Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 63rd American Society of Hematology Annual Meeting and Exposition

Keros Therapeutics will be hosting a conference call and webcast today, December 13, 2021, at 4:01 p.m. ET.LEXINGTON, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that it presented additional data from its ongoing Phase 2 clinical trial of KER-050 in patients with very low-, low-, or intermediate-risk myelodysplastic syndromes (“MDS”), as well as preclinical data on the differentiated mechanism of action of KER-050 and its activity in cytopenia models, at the 63rd American Society of Hematology (“ASH”) Annual Meeting and Exposition, held in person...

Continue reading

Fate Therapeutics Highlights Positive Durability of Response Data from FT516 Phase 1 Study for B-cell Lymphoma and Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to FT516 for Relapsed / Refractory DLBCL

6 of 10 Patients Naïve to Treatment with Autologous CAR T-cell Therapy Continue in Ongoing Response at Median Follow-up of 9.1 Months, including 4 Patients with >6 Months Follow-up, at ≥90 Million FT516 Cells per Dose 3 of 8 Patients Previously Treated with Autologous CAR T-cell Therapy Achieve Complete Response at ≥90 Million FT516 Cells per Dose; 2 Patients Continue in Complete Response at Median Follow-up of 6.5 Months Outpatient Treatment Regimen Was Well-tolerated; No Events of Any Grade of Cytokine Release Syndrome, Immune Effector Cell-Associated Neurotoxicity Syndrome, or Graft-vs-Host Disease Dose-expansion Cohorts Initiated at 900 Million FT516 Cells per Dose, including in Patients with Aggressive B-cell Lymphoma Previously Treated with Autologous CAR T-cell Therapy SAN DIEGO, Dec. 13, 2021 (GLOBE NEWSWIRE) — Fate Therapeutics,...

Continue reading

Freeline Presents Long-Term Follow-Up Data from Phase 1/2 B-AMAZE Trial in Hemophilia B at the 2021 ASH Annual Meeting and Announces Early Initiation of Phase 1/2 B-LIEVE Dose-Confirmation Trial

B-AMAZE long-term follow up data demonstrate sustained FIX expression up to 3.5 years; potential for expression levels in the normal range with relatively low vector doses B-LIEVE trial to confirm dose and immune management for planned Phase 3 pivotal trial launched one quarter ahead of latest guidance LONDON, Dec. 13, 2021 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for patients suffering from inherited systemic debilitating diseases, today presents long-term follow-up data from its Phase 1/2 B-AMAZE dose-finding trial of FLT180a for the treatment of hemophilia B at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition. The event is being held from December 11...

Continue reading

Construction contract termination in Estonia (hotel building in Tallinn)

The construction contract for building a hotel at Tartu mnt 49, entered into on February 12, 2020, between AS Merko Ehitus Eesti, part of AS Merko Ehitus group, and GVP Invest Estonia OÜ was terminated by agreement of the parties. After the pandemic started, the rapidly changing situation on the construction and accommodation markets did not favor starting the construction works under the terms of pending contract, therefore the parties decided to terminate the contract. AS Merko Ehitus Eesti (merko.ee) is Estonian leading construction company, which offers construction services in general construction, civil engineering, road, electrical and residential construction. Additional information: AS Merko Ehitus Eesti Chairman of the Management Board, Mr. Ivo Volkov, tel. +372 680 5105. Urmas SomelarFinantsüksuse juhtAS Merko EhitusTelefon:...

Continue reading

Agreements entered into regarding the sale of one facility for Volvo and Renault in Uppsala, Sweden

Bilia has, as part of the agreement with Volvo Cars dated 1 October 2021, entered into an agreement to sell one facility in Uppsala in Sweden to Bilbolaget Invest Sundsvall AB. The facility conducts sales of new cars, used cars and service for Volvo and Renault. The sale is expected to take place on 1 July 2022. The transfer is subject to approval by the Swedish competition authority. Gothenburg, December 13, 2021 Bilia AB (publ) For information please contact: Per Avander, Managing Director and CEO, +46 (0)10 497 70 00, per.avander@bilia.se  Kristina Franzén, CFO, +46 (0)10 497 73 40, kristina.franzen@bilia.se Facts about the Bilia Group Bilia is one of Europe’s largest car dealers with a leading position within service and sales of cars, transport vehicles and trucks. Bilia has about 160 facilities in Sweden, Norway, Germany, Luxembourg...

Continue reading

Cloud Industry Veteran Brian Goldfarb Joins Tenable as Chief Marketing Officer

COLUMBIA, Md., Dec. 13, 2021 (GLOBE NEWSWIRE) — Tenable®, the Cyber Exposure company, today announced that it has appointed Brian Goldfarb chief marketing officer (CMO). Goldfarb will spearhead Tenable’s global marketing organization, positioning the company for its next phase of growth across all areas of its portfolio, especially cloud security, risk analytics, OT, and identity. Goldfarb is a widely respected industry veteran who has held senior executive roles at some of the most important category-defining companies in the world including Splunk, Salesforce, Google and Microsoft. He joins Tenable from Amperity, the world’s number one enterprise customer data platform. Goldfarb was CMO and senior vice president of business development at Chef Software, which was sold to Progress Software. He led Splunk through a major digital...

Continue reading

Newsweek Names Matthews International One of America’s Most Responsible Companies

PITTSBURGH, Dec. 13, 2021 (GLOBE NEWSWIRE) — Matthews International Corporation (NASDAQ GSM: MATW) announces the Company has been named to Newsweek’s list of America’s Most Responsible Companies of 2022. This award is presented by Newsweek and Statista Inc. This year’s final ranking recognizes 500 of the top 2,000 public companies by revenue with headquarters in the United States. Now in its 3rd year, America’s Most Responsible Companies span fourteen industries and were selected as examples of companies that take a holistic view of corporate responsibility in the three areas of ESG (environmental, social and corporate governance). Statista applied a set of criteria based on publicly available ESG key performance indicators gathered from CSR (corporate social responsibility) Reports, Sustainability Reports, and Corporate Citizenship...

Continue reading

Kona Gold Beverage, Inc. Post Highest November Revenue

Subsidiary Gold Leaf Distribution has another record month Melbourne, FL, Dec. 13, 2021 (GLOBE NEWSWIRE) — Kona Gold Beverage, Inc. (OTCQB: KGKG), a holding company focused on product development in the better-for-you and hemp and CBD functional beverage sector, is pleased to announce it has posted the highest November Revenue in Company history.  November revenues increased over 330% compared to the prior-year November, which is a significant increase.  Total Revenues for November were approximately $236,000. Kona Gold Beverage’s subsidiary, Gold Leaf Distribution, led revenues in November posting another record revenue month with over $183,000 in sales.  Sales for Gold Leaf continue to climb, and the Company expects to see substantial revenue growth as its new Conway, South Carolina distribution center takes root and develops...

Continue reading

SmartCentres Announces Disposition of Non-Core Asset in Maple Ridge B.C.

TORONTO, Dec. 13, 2021 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres” or the “REIT”) (TSX:SRU.UN), announces the disposition of its non-core enclosed mall property, ‘Haney Place Mall’, in Maple Ridge, British Columbia. The property was sold at a sub 5% capitalization rate, representing a premium in excess of 30% over IFRS value. The proceeds from this all-cash transaction will be used to reduce debt and strengthen the balance sheet, as well as free up human capital to further facilitate the REIT’s transformation program.  “The significant gains realized from the sale of this property reflect value embedded in the SmartCentres portfolio as a whole,” said Mitchell Goldhar, Executive Chairman and CEO of SmartCentres. “We are committed to maintaining a strong balance sheet while transitioning our portfolio...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.